Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 2.75% is 489% above its 5-year average of -0.71%, near the high end of its 5-year range (-9.06%–2.94%).
As of the fiscal period ended Monday, June 30, 2025. 13.87% above its 12-month average of 2.42%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
2.75%
RETURN ON ASSETS (ROA) AVG TTM
2.42%
RETURN ON ASSETS (ROA) AVG 3Y
0.86%
RETURN ON ASSETS (ROA) AVG 5Y
-0.71%
RETURN ON ASSETS (ROA) AVG 10Y
1.01%
RETURN ON ASSETS (ROA) AVG 15Y
2.52%
RETURN ON ASSETS (ROA) AVG 20Y
3.27%
CURRENT VS TTM AVG
+13.87%
CURRENT VS 3Y AVG
+218.84%
CURRENT VS 5Y AVG
+489.15%
CURRENT VS 10Y AVG
+171.30%
CURRENT VS 15Y AVG
+9.13%
CURRENT VS 20Y AVG
-15.79%
SECTOR MEDIAN · HEALTHCARE
4.91%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-43.99%
vs the sector median at left
Cardinal Health, Inc.
Market Cap
$53.66B
Return on Assets (ROA)
2.75%
TTM Avg
2.42%
3Y Avg
0.86%
5Y Avg
-0.71%
Market Cap
$49.38B
Return on Assets (ROA)
8.20%
TTM Avg
19.91%
3Y Avg
18.29%
5Y Avg
17.04%
Market Cap
$61.01B
Return on Assets (ROA)
2.24%
TTM Avg
3.00%
3Y Avg
3.04%
5Y Avg
2.95%
Market Cap
$61.99B
Return on Assets (ROA)
3.12%
TTM Avg
2.14%
3Y Avg
2.52%
5Y Avg
0.85%
Market Cap
$44.95B
Return on Assets (ROA)
32.35%
TTM Avg
29.29%
3Y Avg
27.30%
5Y Avg
27.52%
Market Cap
$41.35B
Return on Assets (ROA)
4.60%
TTM Avg
4.82%
3Y Avg
4.76%
5Y Avg
4.01%
Market Cap
$39.63B
Return on Assets (ROA)
10.82%
TTM Avg
10.56%
3Y Avg
11.14%
5Y Avg
10.55%
Market Cap
$68.43B
Return on Assets (ROA)
8.27%
TTM Avg
5.66%
3Y Avg
4.50%
5Y Avg
3.49%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardinal Health, Inc. (CAH) | $53.66B | 2.75% | 2.42% | 0.86% | -0.71% |
| Edwards Lifesciences Corporation (EW)vs › | $49.38B | 8.20% | 19.91% | 18.29% | 17.04% |
| Becton, Dickinson and Company (BDX)vs › | $61.01B | 2.24% | 3.00% | 3.04% | 2.95% |
| Cencora, Inc. (COR)vs › | $61.99B | 3.12% | 2.14% | 2.52% | 0.85% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.95B | 32.35% | 29.29% | 27.30% | 27.52% |
| Humana Inc. (HUM)vs › | $43.93B | 2.24% | 2.52% | 4.20% | 5.49% |
| IQVIA Holdings Inc. (IQV)vs › | $41.35B | 4.60% | 4.82% | 4.76% | 4.01% |
| Agilent Technologies, Inc. (A)vs › | $39.63B | 10.82% | 10.56% | 11.14% | 10.55% |
| Boston Scientific Corporation (BSX)vs › | $68.43B | 8.27% | 5.66% | 4.50% | 3.49% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $38.27B | 11.25% | -0.12% | -10.91% | -15.37% |
ROA
2.8%
ROE
-56.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-06-30 | 2.94% |
| 2024-06-30 | 1.89% |
| 2023-06-30 | 0.76% |
| 2022-06-30 | -2.14% |
| 2021-06-30 | 1.37% |
| 2020-06-30 | -9.06% |
| 2019-06-30 | 3.33% |
| 2018-06-30 | 0.64% |
| 2017-06-30 | 3.21% |
| 2016-06-30 | 4.18% |
| 2015-06-30 | 4.03% |
| 2014-06-30 | 4.48% |
| 2013-06-30 | 1.29% |
| 2012-06-30 | 4.41% |
| 2011-06-30 | 4.20% |
| 2010-06-30 | 3.21% |
| 2009-06-30 | 4.58% |
| 2008-06-30 | 5.55% |
| 2007-06-30 | 8.34% |
| 2006-06-30 | 4.28% |
| 2005-06-30 | 4.76% |
| 2004-06-30 | 6.90% |
| 2003-06-30 | 7.59% |
| 2002-06-30 | 6.43% |
| 2001-06-30 | 5.86% |
| 2000-06-30 | 5.65% |
| 1999-06-30 | 5.43% |
| 1998-06-30 | 3.30% |
| 1997-06-30 | 5.86% |
| 1996-06-30 | 3.96% |
